{
  "metadata": {
    "generated_at": "2025-10-02T04:22:54.748216",
    "dataset": {
      "name": "pharmacy_copilot_pharmacist_eval_v1",
      "description": "Gold pharmacist scenarios for LLM evaluation (enriched for deterministic scoring).",
      "version": "1.2.0"
    },
    "evaluation_time": 48.275120973587036,
    "judge_summary": {
      "mean_score": 85.38461538461539,
      "median_score": 85,
      "count": 13
    }
  },
  "aggregated_metrics": {
    "retrieval": {
      "recall_at_k": {
        "1": 0.6538461538461539,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "precision_at_k": {
        "1": 0.9230769230769231,
        "3": 0.5897435897435896,
        "5": 0.5897435897435896,
        "10": 0.5897435897435896,
        "20": 0.5897435897435896
      },
      "mean_reciprocal_rank": 0.9230769230769231,
      "average_precision": 0.9230769230769231,
      "ndcg_at_k": {
        "1": 0.9230769230769231,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "essential_recall_at_k": {
        "1": 0.9230769230769231,
        "3": 0.9230769230769231,
        "5": 0.9230769230769231,
        "10": 0.9230769230769231,
        "20": 0.9230769230769231
      },
      "first_relevant_rank": 0.9230769230769231,
      "total_relevant": 19,
      "total_essential": 12
    },
    "qa": {
      "bleu_score": 0.024703242770268526,
      "rouge_1_f1": 0.3234550387093805,
      "rouge_2_f1": 0.15331854252196428,
      "rouge_l_f1": 0.2334278865830515,
      "semantic_similarity": 0.6051911069796636,
      "key_points_covered": 0.25274725274725274,
      "key_points_found": [],
      "key_points_missing": [],
      "answer_length": 30,
      "has_answer": true,
      "factual_accuracy": null,
      "helpfulness": null
    }
  },
  "detailed_results": [
    {
      "question_id": "q001",
      "question": "5-year-old (18 kg) with acute otitis media. What is the amoxicillin dose and volume using 400 mg/5 mL suspension?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":810,\"volume_per_dose_mL\":10,\"frequency\":\"q12h\",\"max_daily_mg\":4000,\"rounding\":\"Rounded from 10.1 mL to 10 mL for practical measurement\",\"calc_rule\":\"90 mg/kg/day \u00f7 2 doses = 45 mg/kg/dose; 18 kg \u00d7 45 mg/kg = 810 mg/dose; volume = 810 mg \u00f7 (80 mg/mL)\",\"citations\":[\"lexi-amoxicillin-2018#dosage\",\"lexi-amoxicillin-2018#peds\"],\"notes\":\"High-dose amoxicillin regimen for AOM using 400 mg/5 mL suspension with practical volume rounding per guidance.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 810,
          "volume_per_dose_mL": 10,
          "frequency": "q12h",
          "max_daily_mg": 4000,
          "rounding": "Rounded from 10.1 mL to 10 mL for practical measurement",
          "calc_rule": "90 mg/kg/day \u00f7 2 doses = 45 mg/kg/dose; 18 kg \u00d7 45 mg/kg = 810 mg/dose; volume = 810 mg \u00f7 (80 mg/mL)",
          "citations": [
            "lexi-amoxicillin-2018#dosage",
            "lexi-amoxicillin-2018#peds"
          ],
          "notes": "High-dose amoxicillin regimen for AOM using 400 mg/5 mL suspension with practical volume rounding per guidance."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Amoxicillin 90 mg/kg/day divided q12h \u2192 810 mg per dose (\u224810.1 mL of 400 mg/5 mL), round to 10 mL per dose; max 4 g/day.",
      "judge_assessment": {
        "score": 90,
        "verdict": "pass",
        "rationale": "The answer correctly provides the amoxicillin dose, volume, frequency, and acknowledges the maximum daily dose. It cites allowed chunk IDs and adheres to safety guidelines."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-amoxicillin-2018#dosage",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-amoxicillin-2018#peds",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-amoxicillin-2018#adult-sinusitis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-amoxicillin-2018#dosage",
          "lexi-amoxicillin-2018#peds"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Uses high-dose 80\u201390 mg/kg/day regimen",
        "Per-dose \u2248810 mg for 18 kg",
        "Max daily 4 g acknowledged",
        "No renal adjustment if normal function",
        "Cites pediatric dosage section"
      ]
    },
    {
      "question_id": "q002",
      "question": "12 kg child with fever: acetaminophen dose and volume using 160 mg/5 mL?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":180,\"volume_per_dose_mL\":5.6,\"frequency\":\"q6h\",\"max_daily_mg\":900,\"rounding\":\"Rounded volume from 5.625 mL to 5.6 mL\",\"calc_rule\":\"15 mg/kg/dose \u00d7 12 kg = 180 mg; max 75 mg/kg/day = 900 mg\",\"citations\":[\"lexi-acetaminophen-2018#peds-dosing\",\"lexi-acetaminophen-2018#max\"],\"notes\":\"Oral liquid acetaminophen dosed at 15 mg/kg/dose using 160 mg/5 mL concentration for fever management.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 180,
          "volume_per_dose_mL": 5.6,
          "frequency": "q6h",
          "max_daily_mg": 900,
          "rounding": "Rounded volume from 5.625 mL to 5.6 mL",
          "calc_rule": "15 mg/kg/dose \u00d7 12 kg = 180 mg; max 75 mg/kg/day = 900 mg",
          "citations": [
            "lexi-acetaminophen-2018#peds-dosing",
            "lexi-acetaminophen-2018#max"
          ],
          "notes": "Oral liquid acetaminophen dosed at 15 mg/kg/dose using 160 mg/5 mL concentration for fever management."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Acetaminophen 15 mg/kg/dose q6h (range 10\u201315 mg/kg q4\u20136h) \u2192 180 mg per dose \u22485.6 mL of 160 mg/5 mL; max 75 mg/kg/day (900 mg), and \u22644 g absolute.",
      "judge_assessment": {
        "score": 95,
        "verdict": "pass",
        "rationale": "The answer correctly calculates the acetaminophen dose and volume, cites appropriate evidence chunks, and adheres to safety guidelines."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-acetaminophen-2018#peds-dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-acetaminophen-2018#max",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-acetaminophen-2018#rectal",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-acetaminophen-2018#max",
          "lexi-acetaminophen-2018#peds-dosing"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Per-dose 15 mg/kg used",
        "q4\u20136h acceptable; target q6h in calc",
        "Volume \u22485.625 mL from 32 mg/mL",
        "Daily max 75 mg/kg/day and \u22644 g",
        "Pediatric dosing section cited"
      ]
    },
    {
      "question_id": "q003",
      "question": "12 kg child with fever: ibuprofen dose and volume using 100 mg/5 mL?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":120,\"volume_per_dose_mL\":6.0,\"frequency\":\"q6-8h\",\"max_daily_mg\":480,\"rounding\":\"Rounded to nearest 0.5 mL\",\"calc_rule\":\"10 mg/kg/dose \u00d7 12 kg = 120 mg; volume = 120 mg \u00f7 (100 mg/5 mL) = 6 mL; max 40 mg/kg/day = 480 mg\",\"citations\":[\"lexi-ibuprofen-2018#peds-dosing\",\"lexi-ibuprofen-2018#max\"],\"notes\":\"Weight-based dosing using 100 mg/5 mL suspension with caution in dehydration or renal risk.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 120,
          "volume_per_dose_mL": 6.0,
          "frequency": "q6-8h",
          "max_daily_mg": 480,
          "rounding": "Rounded to nearest 0.5 mL",
          "calc_rule": "10 mg/kg/dose \u00d7 12 kg = 120 mg; volume = 120 mg \u00f7 (100 mg/5 mL) = 6 mL; max 40 mg/kg/day = 480 mg",
          "citations": [
            "lexi-ibuprofen-2018#peds-dosing",
            "lexi-ibuprofen-2018#max"
          ],
          "notes": "Weight-based dosing using 100 mg/5 mL suspension with caution in dehydration or renal risk."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Ibuprofen 10 mg/kg/dose q6\u20138h \u2192 120 mg per dose (6 mL of 100 mg/5 mL); max 40 mg/kg/day (480 mg). Avoid if <6 months or dehydrated/renal issues.",
      "judge_assessment": {
        "score": 90,
        "verdict": "pass",
        "rationale": "The answer correctly provides the ibuprofen dose, volume, frequency, and maximum daily dose, and cites allowed chunk IDs without any disallowed ones."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-ibuprofen-2018#peds-dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-ibuprofen-2018#max",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-ibuprofen-2018#adult-capsules",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-ibuprofen-2018#max",
          "lexi-ibuprofen-2018#peds-dosing"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "10 mg/kg per dose",
        "q6\u20138h frequency",
        "120 mg per dose for 12 kg",
        "6 mL at 20 mg/mL",
        "Contraindication: <6 months; caution renal/dehydration"
      ]
    },
    {
      "question_id": "q004",
      "question": "Elderly patient with nonvalvular AF: 82 years, 58 kg, SCr 1.6 mg/dL. What apixaban dose?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":2.5,\"volume_per_dose_mL\":null,\"frequency\":\"q12h\",\"max_daily_mg\":5,\"rounding\":\"No rounding needed for tablet dose\",\"calc_rule\":\"Meets 2 of 3 criteria for dose reduction: age \u226580y (82y), weight \u226460kg (58kg), SCr \u22651.5mg/dL (1.6mg/dL)\",\"citations\":[\"lexi-apixaban-2018#dosing-nvaf\"],\"notes\":\"Reduced dose of 2.5mg tablets twice daily indicated due to meeting multiple criteria for dose reduction in NVAF.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 2.5,
          "volume_per_dose_mL": null,
          "frequency": "q12h",
          "max_daily_mg": 5,
          "rounding": "No rounding needed for tablet dose",
          "calc_rule": "Meets 2 of 3 criteria for dose reduction: age \u226580y (82y), weight \u226460kg (58kg), SCr \u22651.5mg/dL (1.6mg/dL)",
          "citations": [
            "lexi-apixaban-2018#dosing-nvaf"
          ],
          "notes": "Reduced dose of 2.5mg tablets twice daily indicated due to meeting multiple criteria for dose reduction in NVAF."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Apixaban 2.5 mg BID (meets 2 of 3: age \u226580, weight \u226460 kg, SCr \u22651.5). Avoid with strong CYP3A4/P-gp inhibitors.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly identifies the apixaban dose as 2.5 mg BID based on the criteria met, cites an allowed chunk ID, and does not exceed maximum dosing or violate contraindications."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-apixaban-2018#dosing-nvaf",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-apixaban-2018#ddi",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-apixaban-2018#vte",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-apixaban-2018#ddi",
          "lexi-apixaban-2018#dosing-nvaf"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Final dose 2.5 mg BID",
        "Interaction caveat: strong CYP3A4/P-gp",
        "Hepatic impairment caution"
      ]
    },
    {
      "question_id": "q005",
      "question": "85 kg adult with acute DVT: What is the enoxaparin treatment dose (normal renal function)?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":85,\"volume_per_dose_mL\":0.9,\"frequency\":\"q12h\",\"max_daily_mg\":170,\"rounding\":\"Round to nearest 0.1 mL based on 100 mg/mL concentration\",\"calc_rule\":\"1 mg/kg q12h (preferred regimen) x 85 kg = 85 mg per dose\",\"citations\":[\"lexi-enoxaparin-2018#dosing\"],\"notes\":\"Preferred regimen is 1 mg/kg q12h for acute DVT with normal renal function, with 1.5 mg/kg daily as an alternative.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": 85,
          "volume_per_dose_mL": 0.9,
          "frequency": "q12h",
          "max_daily_mg": 170,
          "rounding": "Round to nearest 0.1 mL based on 100 mg/mL concentration",
          "calc_rule": "1 mg/kg q12h (preferred regimen) x 85 kg = 85 mg per dose",
          "citations": [
            "lexi-enoxaparin-2018#dosing"
          ],
          "notes": "Preferred regimen is 1 mg/kg q12h for acute DVT with normal renal function, with 1.5 mg/kg daily as an alternative."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Enoxaparin 1 mg/kg SC q12h \u2192 85 mg per dose (or 1.5 mg/kg once daily as alternative). If CrCl <30 mL/min: 1 mg/kg once daily.",
      "judge_assessment": {
        "score": 90,
        "verdict": "pass",
        "rationale": "The answer correctly provides the enoxaparin treatment dose of 85 mg per dose, cites the appropriate chunk ID, and includes the alternative dosing regimen. It adheres to safety guidelines without exceeding maximum doses."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-enoxaparin-2018#dosing",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-enoxaparin-2018#renal",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-enoxaparin-2018#prophylaxis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-enoxaparin-2018#dosing",
          "lexi-enoxaparin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Renal adjustment for CrCl <30"
      ]
    },
    {
      "question_id": "q006",
      "question": "Type 2 diabetes patient with eGFR 28 mL/min/1.73 m\u00b2. Can we use metformin?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"n/a\",\"max_daily_mg\":null,\"rounding\":\"n/a\",\"calc_rule\":\"eGFR <30 mL/min/1.73m\u00b2 = contraindicated\",\"citations\":[\"lexi-metformin-2018#renal\"],\"notes\":\"Metformin is contraindicated in this patient with eGFR 28 mL/min/1.73m\u00b2 due to risk of lactic acidosis.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "n/a",
          "max_daily_mg": null,
          "rounding": "n/a",
          "calc_rule": "eGFR <30 mL/min/1.73m\u00b2 = contraindicated",
          "citations": [
            "lexi-metformin-2018#renal"
          ],
          "notes": "Metformin is contraindicated in this patient with eGFR 28 mL/min/1.73m\u00b2 due to risk of lactic acidosis."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "No\u2014contraindicated at eGFR <30. If 30\u201345, generally avoid initiation; if continuing, reduce dose and monitor. Avoid in hepatic impairment.",
      "judge_assessment": {
        "score": 80,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies that metformin is contraindicated at eGFR <30, but it does not mention the recommendation for patients with eGFR 30\u201345. It cites one allowed chunk ID but misses another relevant one, which affects the completeness of the evidence support."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-metformin-2018#renal",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-metformin-2018#contra",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-metformin-2018#old-crcl60",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-metformin-2018#contra",
          "lexi-metformin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "30\u201345: avoid initiation; if continuing, reduce & monitor",
        "Hepatic impairment: avoid (lactic acidosis risk)"
      ]
    },
    {
      "question_id": "q007",
      "question": "Uncomplicated cystitis: Should we use nitrofurantoin if eGFR is 25?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"Not applicable - contraindicated\",\"calc_rule\":\"Contraindicated if eGFR <30 mL/min\",\"citations\":[\"lexi-nitrofurantoin-2018#renal\",\"lexi-nitrofurantoin-2018#contra\"],\"notes\":\"Nitrofurantoin is contraindicated at eGFR 25 mL/min due to inadequate urinary concentrations and increased toxicity risk.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "Not applicable - contraindicated",
          "calc_rule": "Contraindicated if eGFR <30 mL/min",
          "citations": [
            "lexi-nitrofurantoin-2018#renal",
            "lexi-nitrofurantoin-2018#contra"
          ],
          "notes": "Nitrofurantoin is contraindicated at eGFR 25 mL/min due to inadequate urinary concentrations and increased toxicity risk."
        },
        "failure_types": [
          "qa_incomplete"
        ]
      },
      "expected_answer": "Avoid nitrofurantoin when eGFR/CrCl <30 mL/min due to low urinary levels and toxicity risk.",
      "judge_assessment": {
        "score": 90,
        "verdict": "pass",
        "rationale": "The answer correctly states to avoid nitrofurantoin if eGFR <30 mL/min, cites relevant evidence chunks, and provides a rationale for the contraindication."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-nitrofurantoin-2018#renal",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-nitrofurantoin-2018#contra",
            "score": 0.0,
            "rank": 2
          },
          {
            "chunk_id": "lexi-nitrofurantoin-2018#prophylaxis",
            "score": 0.0,
            "rank": 3
          }
        ],
        "relevant_chunks_found": [
          "lexi-nitrofurantoin-2018#contra",
          "lexi-nitrofurantoin-2018#renal"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Avoid if eGFR/CrCl <30",
        "Rationale: efficacy/toxicity",
        "List common contraindications where relevant"
      ]
    },
    {
      "question_id": "q008",
      "question": "Patient on warfarin needs TMP-SMX for UTI. Any interaction and what should we do?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"n/a\",\"max_daily_mg\":null,\"rounding\":\"n/a\",\"calc_rule\":\"Drug interaction via CYP2C9 inhibition and gut flora changes\",\"citations\":[\"lexi-warfarin-2018#ddi-tmp-smx\"],\"notes\":\"TMP-SMX markedly increases warfarin effect requiring warfarin dose reduction and increased INR monitoring, with preference for alternative antibiotics.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "n/a",
          "max_daily_mg": null,
          "rounding": "n/a",
          "calc_rule": "Drug interaction via CYP2C9 inhibition and gut flora changes",
          "citations": [
            "lexi-warfarin-2018#ddi-tmp-smx"
          ],
          "notes": "TMP-SMX markedly increases warfarin effect requiring warfarin dose reduction and increased INR monitoring, with preference for alternative antibiotics."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction (CYP2C9 inhibition + gut flora). Avoid if possible; otherwise increase INR monitoring and reduce warfarin dose.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The answer correctly identifies the major interaction mechanism and appropriate actions, and it cites an allowed chunk ID."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-warfarin-2018#ddi-tmp-smx",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-warfarin-2018#ddi-cephalexin",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-warfarin-2018#ddi-tmp-smx"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Severity: major",
        "Action: avoid or close INR monitoring with dose reduction"
      ]
    },
    {
      "question_id": "q009",
      "question": "Patient on atorvastatin needs clarithromycin. What\u2019s the risk and action?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"hold\",\"max_daily_mg\":null,\"rounding\":\"not applicable\",\"calc_rule\":\"hold atorvastatin during clarithromycin due to CYP3A4 inhibition; if unavoidable use lowest dose with monitoring\",\"citations\":[\"lexi-atorvastatin-2018#ddi-macrolides\"],\"notes\":\"Major interaction increases myopathy/rhabdomyolysis risk through strong CYP3A4 inhibition.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "hold",
          "max_daily_mg": null,
          "rounding": "not applicable",
          "calc_rule": "hold atorvastatin during clarithromycin due to CYP3A4 inhibition; if unavoidable use lowest dose with monitoring",
          "citations": [
            "lexi-atorvastatin-2018#ddi-macrolides"
          ],
          "notes": "Major interaction increases myopathy/rhabdomyolysis risk through strong CYP3A4 inhibition."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Major interaction (strong CYP3A4 inhibitor). Avoid coadministration; if unavoidable, hold atorvastatin or limit to the lowest dose and monitor for myopathy.",
      "judge_assessment": {
        "score": 75,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies the major interaction and mechanism but does not explicitly state 'avoid coadministration' as required. It also provides appropriate action but lacks clarity in the phrasing of the action. The citation is valid."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-atorvastatin-2018#ddi-macrolides",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-atorvastatin-2018#ddi-azithro",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-atorvastatin-2018#ddi-macrolides"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Severity: major"
      ]
    },
    {
      "question_id": "q010",
      "question": "Starting linezolid in a patient on sertraline. Is this safe?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"n/a\",\"max_daily_mg\":null,\"rounding\":\"n/a\",\"calc_rule\":\"Contraindicated due to MAOI activity unless benefits outweigh risks\",\"citations\":[\"lexi-linezolid-2018#ddi-ssri\"],\"notes\":\"Avoid combination due to serotonin syndrome risk; if necessary, withhold SSRI and monitor closely.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "n/a",
          "max_daily_mg": null,
          "rounding": "n/a",
          "calc_rule": "Contraindicated due to MAOI activity unless benefits outweigh risks",
          "citations": [
            "lexi-linezolid-2018#ddi-ssri"
          ],
          "notes": "Avoid combination due to serotonin syndrome risk; if necessary, withhold SSRI and monitor closely."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "Major interaction: risk of serotonin syndrome (linezolid has MAOI activity). Avoid; if benefits outweigh risks, withhold SSRI or monitor very closely.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The model correctly identifies the major interaction and provides appropriate actions, citing the allowed chunk ID."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-linezolid-2018#ddi-ssri",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-linezolid-2018#ddi-penicillins",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-linezolid-2018#ddi-ssri"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: MAOI activity \u2192 \u2191serotonin",
        "Severity: major",
        "Action: avoid; or stop SSRI/close monitoring if unavoidable"
      ]
    },
    {
      "question_id": "q011",
      "question": "Patient on digoxin will start amiodarone. What\u2019s the interaction management?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"maintain current\",\"max_daily_mg\":null,\"rounding\":\"reduce current dose by 30-50%\",\"calc_rule\":\"reduce existing digoxin dose by 30-50% due to P-glycoprotein inhibition\",\"citations\":[\"lexi-digoxin-2018#ddi-amio\"],\"notes\":\"Reduce digoxin dose by 30-50% when starting amiodarone and monitor digoxin levels, renal function, and ECG.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "maintain current",
          "max_daily_mg": null,
          "rounding": "reduce current dose by 30-50%",
          "calc_rule": "reduce existing digoxin dose by 30-50% due to P-glycoprotein inhibition",
          "citations": [
            "lexi-digoxin-2018#ddi-amio"
          ],
          "notes": "Reduce digoxin dose by 30-50% when starting amiodarone and monitor digoxin levels, renal function, and ECG."
        },
        "failure_types": [
          "retrieval_irrelevant",
          "qa_incomplete"
        ]
      },
      "expected_answer": "Major interaction (P-gp inhibition). Reduce digoxin dose by ~30\u201350% and monitor levels/ECG.",
      "judge_assessment": {
        "score": 75,
        "verdict": "manual_review",
        "rationale": "The answer correctly identifies the interaction and recommends a dose reduction of 30-50%, but it lacks clarity in the mechanism and severity. It cites the correct chunk ID, but the phrasing could be more aligned with the expected answer."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-digoxin-2018#ddi-amio",
            "score": 0.0,
            "rank": 1
          },
          {
            "chunk_id": "lexi-digoxin-2018#ddi-verapamil",
            "score": 0.0,
            "rank": 2
          }
        ],
        "relevant_chunks_found": [
          "lexi-digoxin-2018#ddi-amio"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Mechanism: P-gp inhibition \u2192 \u2191digoxin",
        "Severity: major"
      ]
    },
    {
      "question_id": "q012",
      "question": "COVID-19 patient asks for Paxlovid dosing and interaction checks.",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"Not applicable - insufficient data\",\"calc_rule\":\"Cannot calculate - predates COVID-19 therapies\",\"citations\":[\"kb-scope-2018#covid-absent\"],\"notes\":\"Knowledge base predates COVID-19 therapies including Paxlovid (nirmatrelvir/ritonavir); refer to current clinical guidance and pharmacist.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "Not applicable - insufficient data",
          "calc_rule": "Cannot calculate - predates COVID-19 therapies",
          "citations": [
            "kb-scope-2018#covid-absent"
          ],
          "notes": "Knowledge base predates COVID-19 therapies including Paxlovid (nirmatrelvir/ritonavir); refer to current clinical guidance and pharmacist."
        },
        "failure_types": [
          "retrieval_miss",
          "retrieval_irrelevant",
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "ABSTAIN. Not in \u22642018 corpus; recency-sensitive therapy. Advise consulting current guidance/pharmacist.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "Correctly abstains and advises consulting current guidance; cites allowed chunk ID."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "kb-scope-2018#covid-absent",
            "score": 0.0,
            "rank": 1
          }
        ],
        "relevant_chunks_found": [],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Explicit abstention",
        "Sets recency_risk = true",
        "Advises pharmacist/current guidance"
      ]
    },
    {
      "question_id": "q013",
      "question": "What is the current first-line pharmacologic therapy per latest hypertension guidelines?",
      "llm_response": {
        "raw_answer": "{\"dose_per_dose_mg\":null,\"volume_per_dose_mL\":null,\"frequency\":\"\",\"max_daily_mg\":null,\"rounding\":\"Not applicable\",\"calc_rule\":\"No current dosing available\",\"citations\":[\"lexi-hypertension-2014#jnc8\"],\"notes\":\"Cannot provide current first-line therapy as available guideline data from JNC8 (2014) is outdated.\"}",
        "parsed_answer": {
          "dose_per_dose_mg": null,
          "volume_per_dose_mL": null,
          "frequency": "",
          "max_daily_mg": null,
          "rounding": "Not applicable",
          "calc_rule": "No current dosing available",
          "citations": [
            "lexi-hypertension-2014#jnc8"
          ],
          "notes": "Cannot provide current first-line therapy as available guideline data from JNC8 (2014) is outdated."
        },
        "failure_types": [
          "qa_incorrect",
          "qa_incomplete",
          "e2e_low_quality"
        ]
      },
      "expected_answer": "ABSTAIN if asked for \u2018current\u2019 guidance (2018 corpus includes JNC8/2014). Flag recency risk.",
      "judge_assessment": {
        "score": 85,
        "verdict": "pass",
        "rationale": "The model correctly abstains from providing current guidelines, recognizes the outdated nature of JNC8 (2014), and cites the appropriate chunk ID."
      },
      "retrieval_performance": {
        "retrieved_chunks": [
          {
            "chunk_id": "lexi-hypertension-2014#jnc8",
            "score": 0.0,
            "rank": 1
          }
        ],
        "relevant_chunks_found": [
          "lexi-hypertension-2014#jnc8"
        ],
        "essential_chunks_missed": []
      },
      "key_points_missing": [
        "Explicit abstention for \u2018current\u2019 guideline ask",
        "Recognize JNC8 (2014) is outdated for \u2018current\u2019",
        "Sets recency_risk = true"
      ]
    }
  ]
}